Targeting of Nuclear Factor κB Pathways by Dehydroxymethylepoxyquinomicin, a Novel Inhibitor of Breast Carcinomas: Antitumor and Antiangiogenic Potential In vivo
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.